Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 4 completed trials

    Completion Rate
    100%(4/4)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 2
    1
    25%
    Phase 1
    3
    75%

    Phase Distribution

    3

    Early Stage

    1

    Mid Stage

    0

    Late Stage

    Phase Distribution4 total trials
    Phase 1Safety & dosage
    3(75.0%)
    Phase 2Efficacy & side effects
    1(25.0%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    100.0%

    4 of 4 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    4

    all time

    Status Distribution
    Completed(4)

    Detailed Status

    Completed4

    Development Timeline

    Analytics

    Development Status

    Total Trials
    4
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 2

    Trials by Phase

    Phase 13 (75.0%)
    Phase 21 (25.0%)

    Trials by Status

    completed4100%

    Recent Activity

    0 active trials
    Showing 4 of 4
    completedphase_2

    STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease

    NCT05843578
    completedphase_1

    A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants

    NCT07118878
    completedphase_1

    Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants

    NCT05937386
    completedphase_1

    Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants

    NCT06397508

    Clinical Trials (4)

    Showing 4 of 4 trials
    NCT05843578Phase 2

    STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease

    Completed
    NCT07118878Phase 1

    A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants

    Completed
    NCT05937386Phase 1

    Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants

    Completed
    NCT06397508Phase 1

    Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants

    Completed

    All 4 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    4